Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Concentra Biosciences To Acquire CARGO Therapeutics For $4.379 Cash Per Share Plus Contingent Value Right, Deal Expected To Close August 2025

Author: Benzinga Newsdesk | July 08, 2025 06:04am

Concentra will acquire CARGO for $4.379 in cash per share of CARGO common stock, par value $0.001 per share ("CARGO Common Stock"), plus one non-transferable contingent value right ("CVR"), which represents the right to receive:

 (i) 100% of the closing net cash of CARGO in excess of $217.5 million; and 

(ii) 80% of any net proceeds received within two years following closing from any disposition of certain of CARGO's product candidates that occurs within two years following closing, each pursuant to a contingent value rights agreement

Posted In: CRGX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist